BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 20438349)

  • 41. Prevalence and antimicrobial susceptibility patterns of Shigella species in Asmara, Eritrea, northeast Africa.
    Naik DG
    J Microbiol Immunol Infect; 2006 Oct; 39(5):392-5. PubMed ID: 17066201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid emergence of third-generation cephalosporin resistance in Shigella sp. isolated in Andaman and Nicobar Islands, India.
    Bhattacharya D; Purushottaman SA; Bhattacharjee H; Thamizhmani R; Sudharama SD; Manimunda SP; Bharadwaj AP; Singhania M; Roy S
    Microb Drug Resist; 2011 Jun; 17(2):329-32. PubMed ID: 21352076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections.
    Thompson CN; Thieu NT; Vinh PV; Duc AN; Wolbers M; Vinh H; Campbell JI; Ngoc DT; Hoang NV; Thanh TH; The HC; Nguyen TN; Lan NP; Parry CM; Chau NV; Thwaites G; Thanh DP; Baker S
    J Antimicrob Chemother; 2016 Mar; 71(3):807-15. PubMed ID: 26679253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Childhood shigellosis: clinical and bacteriological study.
    Daoud AS; Zaki M; al-Mutairi G; West PW; el Saleh Q
    J Trop Med Hyg; 1990 Aug; 93(4):275-9. PubMed ID: 2202839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiresistant Shigella species isolated from pediatric patients with acute diarrheal disease.
    Flores A; Araque M; Vizcaya L
    Am J Med Sci; 1998 Dec; 316(6):379-84. PubMed ID: 9856691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
    J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Analysis on the status of Shigella spp antimicrobial resistance through data from the National Shigellosis Surveillance System in China, in 2005].
    Yu HL; Chang ZR; Zhang LS; Zhang J; Li ZJ; Xu JG; Ran L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):370-3. PubMed ID: 17850709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru).
    Lluque A; Mosquito S; Gomes C; Riveros M; Durand D; Tilley DH; Bernal M; Prada A; Ochoa TJ; Ruiz J
    Int J Med Microbiol; 2015; 305(4-5):480-90. PubMed ID: 25998616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and antimicrobial susceptibility patterns of shigella species at Felege Hiwot Referral Hospital, Northwest Ethiopia.
    Debas G; Kibret M; Biadglegne F; Abera B
    Ethiop Med J; 2011 Jul; 49(3):249-56. PubMed ID: 21991758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial resistance trends of shigellae isolates from Calabar, Nigeria.
    Eko FO; Utsalo SJ
    J Trop Med Hyg; 1991 Dec; 94(6):407-10. PubMed ID: 1758013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antimicrobial resistance of Shigella spp. in Córdoba, Argentina, during the period 1990-1997].
    Suárez ME; Carvajal L; Culasso C; Paredes M
    Rev Panam Salud Publica; 2000 Feb; 7(2):113-7. PubMed ID: 10748662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increasing Antibiotic Resistance in Shigella spp. from Infected New York City Residents, New York, USA.
    Murray K; Reddy V; Kornblum JS; Waechter H; Chicaiza LF; Rubinstein I; Balter S; Greene SK; Braunstein SL; Rakeman JL; Dentinger CM
    Emerg Infect Dis; 2017 Feb; 23(2):332-335. PubMed ID: 28098543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changing patterns of drug-resistant Shigella isolates in egypt.
    Abd-Elmeged GM; Khairy RM; Abo-Eloyoon SM; Abdelwahab SF
    Microb Drug Resist; 2015 Jun; 21(3):286-91. PubMed ID: 25495749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shigella antibiotic resistance in central Turkey: comparison of the years 1987-1994 and 1995-2002.
    Ozmert EN; Göktürk B; Yurdakök K; Yalçin SS; Gür D
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):359-62. PubMed ID: 15735493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shigella isolates in stool.
    Pearce P; Ghuman H; Prabhakar H; Hobbs BC
    Indian J Pathol Microbiol; 1995 Apr; 38(2):173-5. PubMed ID: 8919104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution.
    Bangtrakulnonth A; Vieira AR; Lo Fo Wong DM; Pornreongwong S; Pulsrikarn C; Sawanpanyalert P; Hendriksen RS; Aarestrup FM
    Foodborne Pathog Dis; 2008 Dec; 5(6):773-84. PubMed ID: 19086804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers.
    Haukka K; Siitonen A
    Epidemiol Infect; 2008 Apr; 136(4):476-82. PubMed ID: 17578602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [High percentage of antibiotic resistance in Shigella infections in children in Curaçao].
    Wolfs TF; van Woensel JB; Muskiet FD
    Ned Tijdschr Geneeskd; 1996 Dec; 140(50):2510-3. PubMed ID: 9005333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotype distribution and antimicrobial resistance of Shigella isolates in Singapore.
    Lim YS; Tay L
    J Diarrhoeal Dis Res; 1991 Dec; 9(4):328-31. PubMed ID: 1800565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An 11-year study of shigellosis and Shigella species in Taiyuan, China: Active surveillance, epidemic characteristics, and molecular serotyping.
    Zhao L; Xiong Y; Meng D; Guo J; Li Y; Liang L; Han R; Wang Y; Guo X; Wang R; Zhang L; Gao L; Wang J
    J Infect Public Health; 2017; 10(6):794-798. PubMed ID: 28188118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.